Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorGürbüz, Melahat
dc.date.accessioned2025-12-28T17:02:17Z
dc.date.available2025-12-28T17:02:17Z
dc.date.issued2025
dc.identifier.issn2619-9041
dc.identifier.urihttps://doi.org/10.19127/bshealthscience.1623545
dc.identifier.urihttps://hdl.handle.net/20.500.12933/3462
dc.description.abstractThe indirect immunofluorescence (IIF) method for anti-nuclear antibody (ANA) testing is pivotal in the diagnosis of autoimmune diseases. Despite extensive research on nuclear staining patterns, cytoplasmic and mitotic patterns remain less understood. This study retrospectively analyzed 12,674 ANA test results from a tertiary medical microbiology laboratory over three years to assess the prevalence and diagnostic implications of these patterns. ANA positivity was observed in 24.2% of samples, with cytoplasmic and mitotic patterns accounting for 9.2%. Notably, these patterns were predominantly found in ANA-negative samples, with intercellular bridge (AC-27) emerging as the most frequent pattern. While a substantial proportion of cytoplasmic and mitotic patterns were detected among rheumatology patients, no significant correlation was identified between specific patterns and autoimmune diagnoses. These findings underscore the importance of consistent reporting of cytoplasmic and mitotic patterns, as recommended by the International Consensus on ANA Patterns (ICAP). The incorporation of these patterns into routine diagnostic reports has the potential to enhance diagnostic accuracy, particularly in cases ANA-negative. Further research is essential to elucidate their clinical significance and optimize laboratory practices.
dc.description.abstractThe indirect immunofluorescence (IIF) method for anti-nuclear antibody (ANA) testing is pivotal in the diagnosis of autoimmune diseases. Despite extensive research on nuclear staining patterns, cytoplasmic and mitotic patterns remain less understood. This study retrospectively analyzed 12,674 ANA test results from a tertiary medical microbiology laboratory over three years to assess the prevalence and diagnostic implications of these patterns. ANA positivity was observed in 24.2% of samples, with cytoplasmic and mitotic patterns accounting for 9.2%. Notably, these patterns were predominantly found in ANA-negative samples, with intercellular bridge (AC-27) emerging as the most frequent pattern. While a substantial proportion of cytoplasmic and mitotic patterns were detected among rheumatology patients, no significant correlation was identified between specific patterns and autoimmune diagnoses. These findings underscore the importance of consistent reporting of cytoplasmic and mitotic patterns, as recommended by the International Consensus on ANA Patterns (ICAP). The incorporation of these patterns into routine diagnostic reports has the potential to enhance diagnostic accuracy, particularly in cases ANA-negative. Further research is essential to elucidate their clinical significance and optimize laboratory practices.
dc.language.isoen
dc.publisherCem TIRINK
dc.relation.ispartofBlack Sea Journal of Health Science
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subject?Internal Diseases
dc.subjectİç Hastalıkları
dc.subjectEpidemiology (Other)
dc.subjectEpidemiyoloji (Diğer)
dc.titleEvaluation of Hep-2 Cell Patterns: How Often Do We Report Cytoplasmic and Mitotic Patterns?
dc.title.alternativeEvaluation of Hep-2 Cell Patterns: How Often Do We Report Cytoplasmic and Mitotic Patterns?
dc.typeArticle
dc.departmentAfyonkarahisar Sağlık Bilimleri Üniversitesi
dc.identifier.doi10.19127/bshealthscience.1623545
dc.identifier.volume8
dc.identifier.issue4
dc.identifier.startpage139
dc.identifier.endpage144
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.department-tempAFYONKARAHİSAR SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, 0000-0001-6290-1216, Türkiye
dc.snmzKA_DergiPark_20251227


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster